These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1655296)
1. [Expression of p21 in hepatocellular carcinoma and liver cirrhosis and its relation with HBV infection]. Ren CS Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):88-90. PubMed ID: 1655296 [TBL] [Abstract][Full Text] [Related]
2. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia]. Feng Z; He R; Lu Z; Ling Y Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691 [TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Seo JH; Park BC Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling. Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807 [TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies. Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease. Yusof YA; Yan KL; Hussain SN Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299 [TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
8. [Expression of GST-pi and HBV infection in hepatocellular carcinoma]. Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma. Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055 [TBL] [Abstract][Full Text] [Related]
10. [Expression of c-erbB-2 protein and EGF receptor in hepatitis B, cirrhosis and hepatocellular carcinoma]. Su Q; Liu Y Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):93-5. PubMed ID: 7788735 [TBL] [Abstract][Full Text] [Related]
12. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma. Zhou XD; DeTolla L; Custer RP; London WT Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601 [TBL] [Abstract][Full Text] [Related]
13. [Expression of CAS in hepatocellular carcinoma tissues and its relationship with HBV infection]. Zang H; Zhao JM; Ji D; Sun YL; Zhou GD; Zhao YL; Chen GF Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):285-7. PubMed ID: 23189846 [TBL] [Abstract][Full Text] [Related]
14. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma]. DU JL; Wei LX; Wang YL Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352 [TBL] [Abstract][Full Text] [Related]
15. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma. SzczepaĆski W Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407 [TBL] [Abstract][Full Text] [Related]
16. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease. Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926 [TBL] [Abstract][Full Text] [Related]
17. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E; Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564 [TBL] [Abstract][Full Text] [Related]
18. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218 [TBL] [Abstract][Full Text] [Related]
20. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma. Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T Platelets; 2015; 26(6):577-82. PubMed ID: 25275728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]